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OBJECTIVES: Variations in sex hormones and the calcium balance can influence bone health in men. The present
study aimed to examine the relationship between the calcaneal speed of sound and biochemical determinants of
bone mass, such as sex hormones, parathyroid hormones and serum calcium.
METHODS: Data from 549 subjects from the Malaysian Aging Male Study, which included Malay and Chinese men
aged 20 years and older residing in the Klang Valley, were used for analysis. The subjects’ calcaneal speed of sound
was measured, and their blood was collected for biochemical analysis. Two sets of multiple regression models were
generated for the total/bioavailable testosterone and estradiol to avoid multicollinearity.
RESULTS: The multiple regression results revealed that bioavailable testosterone and serum total calcium were
significant predictors of the calcaneal speed of sound in the adjusted model. After adjustment for ethnicity and
body mass index, only bioavailable testosterone remained significant; the total serum calcium was marginally
insignificant. In a separate model, the total testosterone and sex hormone-binding globulin were significant
predictors, whereas the total serum calcium was marginally insignificant. After adjustment for ethnicity and body
mass index (BMI), the significance persisted for total testosterone and SHBG. After further adjustment for age, none
of the serum biochemical determinants was a significant predictor of the calcaneal speed of sound.
CONCLUSION: There is a significant age-dependent relationship between the calcaneal speed of sound and total
testosterone, bioavailable testosterone and sex hormone-binding globulin in Chinese and Malay men in Malaysia.
The relationship between total serum calcium and calcaneal speed of sound is ethnicity-dependent.
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INTRODUCTION
Osteoporosis is a systemic disease that is characterized by
low bone density and deterioration of the bone microarch-
itecture, which lead to bone fragility and subsequent
fractures (1). Men and women both suffer from osteoporosis,
but the prevalence of fracture is lower in men than in women
because men have a comparatively higher peak bone density
and do not undergo a phase of accelerated bone loss (2).
However, men suffer from greater morbidity and mortality
after fracture than women (3). With the continual increase in
lifespan, the burden of male osteoporosis on the healthcare
system will continue to grow, especially in developing
countries (4).
Bone mineral density (BMD) measurement using dual-
energy X-ray absorptiometry (DXA) is the current gold
standard for diagnosing osteoporosis (5). However, the cost
and availability of DXA prevent its wide usage for
osteoporosis screening in developing countries. Quantita-
tive ultrasound (QUS) technology is an emerging technology
that provides an alternative to DXA. It is relatively less costly,
easier to handle, free of ionizing emission, portable and thus
more accessible than DXA (6). Calcaneal speed of sound
(SOS), which is a QUS index, has been shown to correlate
strongly with bone density (7,8).
The role of testosterone in bone health has been confirmed
by the observation that hypogonadal males have a lower
BMD (9,10). The relationship between estradiol and bone
health has also been shown in several ‘‘natural experi-
ments’’. Males who express mutated estradiol receptors (11)
or malfunctioning aromatase enzymes (12,13) have been
Copyright  2012 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
CLINICS 2012;67(8):911-916 DOI:10.6061/clinics/2012(08)10
911
reported to experience abnormal bone growth and low bone
density. This finding is further confirmed by experimental
studies in which male subjects with suppressed expression
of testosterone, estradiol, or both sex hormones exhibited
higher bone turnover (14,15). Fewer studies have estab-
lished a relationship between sex hormones and QUS
indices.
Changes in calcium absorption can also contribute to
osteoporosis in men. Studies have shown that there is a
concurrent decline in BMD when calcium absorption is
reduced in men (16). The decline in calcium absorption may
trigger a feedback mechanism via the parathyroid (PTH)
hormone, whereby bone resorption is increased to maintain
the calcium balance in the blood (17). The relationship
between PTH levels and BMD has been established (18).
However, no study to date has attempted to correlate the
variations in serum calcium and PTH levels with calcaneal
QUS indices.
We previously indicated that the calcaneal SOS measured
using a CM-200 sonometer (Furuno, Nishinomiya City,
Japan) demonstrates an age-related decline in a healthy
Malaysian male population (19). The present study aimed to
explore whether the decline in calcaneal SOS is related to
variations in biochemical determinants such as sex hor-
mones, serum calcium and PTH levels in a population of
healthy Malaysian men composed of men aged 20 years and
older from two major ethnic groups, Chinese and Malays.
The information from this study will provide a better
understanding of the biochemical variables that influence
QUS indices in men, thus enabling a wider application of
the technology for osteoporosis screening. It will also help to
identify potential areas of intervention that can prevent the
progress of osteopenia and osteoporosis in aging men.
MATERIALS AND METHODS
Study design
The present study was conducted as part of the Malaysian
Aging Male Study, which aimed to determine the nutri-
tional, oxidative and bone health of healthy Malaysian men
aged 20 years and older. It was a cross-sectional study, and
subjects were recruited from September 2009 to September
2011. Purposive sampling was used, and subjects were
recruited via advertisements in major newspapers, radio
broadcasts, flyers and public announcements through
community centers and religious facilities. The details of
the study, including the specific inclusion and exclusion
criteria, were clearly stated in the advertisement. The
original sample size derived from the Malaysian Aging
Male study was 840 subjects; 570 of these subjects consented
to blood draws for biochemical testing, and their data were
used for analysis. This study was approved by the Ethics
Committee of Universiti Kebangsaan Malaysia Medical
Center (UKMMC), Research Project Code: UKM-AP-TKP-
09-2009 and FF-376-2010.
Subjects
The subjects who volunteered for this study were males
aged 20 years and older of Malay and Chinese ethnicity who
resided in the Klang Valley of Peninsular Malaysia (Kuala
Lumpur, Shah Alam, Klang, Petaling Jaya, Gombak).
All of the subjects were screened using a detailed demo-
graphic questionnaire and their previous medical records.
Physical examinations and medical history interviews were
conducted by qualified physicians. Subjects with the
following conditions were excluded: 1) mobility impairment
(requiring walking aids); 2) bone fracture six months prior
to screening; 3) major systemic diseases affecting bone
metabolism, such as osteoporosis, osteomalacia, osteogen-
esis imperfecta, rickets, Paget’s disease, hyper/hypocalce-
mia and hyper/hypoparathyroidism; and 4) taking medi-
cations known to affect bone metabolism, such as testoster-
one, thyroid hormones, thiazide, diuretics, glucocorticoids,
bisphosphonate, anticonvulsants and lithium. All of the
subjects received detailed information regarded the study,
and written consent was obtained.
Body anthropometric measurements
The subjects’ weight in light clothing and without shoes
was determined using a standardized balance beam scale
and was recorded to the nearest 0.1 kg. The subjects’
standing height without shoes was determined using a
portable stadiometer and was recorded to the nearest
0.1 cm. The subjects’ body mass index (BMI) was calculated
using the formula BMI (kg/m2) = body weight (kg)/height
squared (m2).
Calcaneal speed of sound measurement
The subjects’ calcaneal SOS was determined using a CM-
200 sonometer (Furuno, Noshinomiya City, Japan), which
measured the speed of sound (SOS) passing through the
subject’s calcaneus as a determinant of bone health status.
The CM-200 is a gel-coupled (dry) system that consists of
two transducers. The subjects were required to place their
right foot on the foot patch, which was adjusted to their foot
size. The sound waves emitted from one transducer were
transmitted through the calcaneus and received by another
transducer. The signal was then analyzed and sent to the
computer for storage and display. Three readings with
repositioning were obtained for each subject. All measure-
ments were performed by a trained technician. The
instruments were calibrated prior to each screening session,
and quality control was conducted using a phantom. The
short-term in-vivo coefficient of variation for the device was
approximately 0.1%.
Laboratory assays
All of the subjects were required to fast for at least eight
hours before attending the screening sessions. During the
fasting period, they were not allowed to consume any food
or beverages except plain water. Venipuncture was per-
formed between 08:30 and 10:30. The blood was collected in
plain tubes, and the serum was extracted. Part of the serum
was sent immediately for total testosterone, total estradiol,
total calcium, inorganic phosphate and albumin assays. The
remaining serum was stored at -70 C˚ for sex hormone-
binding globulin (SHBG) and intact parathyroid (PTH) level
measurement. The storage period for the serum was one to
six months. Total testosterone and total estradiol levels were
measured using an ADVIA Centaur immunoassay system
(Siemens Healthcare Diagnostics, Illinois, USA) based on
competitive immunoassay with direct chemiluminescent
technology. The free and bioavailable fractions of testoster-
one and estradiol were calculated using methods previously
described by So¨derga˚rd et al. (1982) (20). Total calcium,
inorganic phosphate and albumin were measured with the
ADVIA 2400 (Siemens Healthcare Diagnostics, Illinois,
USA) using colorimetric methods. SHBG and PTH were
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measured using solid phase enzyme-linked immunosorbent
assay (ELISA) kits based on the sandwich principle (IBL
International, Hamburg, Germany). The manufacturers’ test
principles and procedures were followed.
Data analysis
The normality of the data was determined using the
Shapiro-Wilk test. A log10 transformation was attempted for
the SHBG and PTH levels, which reverted to normal; thus,
the log10 values were used for analysis. However, the
estradiol levels remained skewed after conventional trans-
formation methods were attempted. Therefore, the estradiol
levels were recoded into tertiles as ‘low’, ‘moderate’, and
‘high’ levels for analysis. Normally distributed data were
presented as the mean (standard deviation [SD]) and
skewed data were presented as the median (interquartile
range [IQR]). Age, body anthropometry, calcaneal SOS and
serum biochemical determinants were compared between
the Chinese and Malay subjects using independent t-tests
for normal data and Mann-Whitney U-tests for skewed data.
A univariate analysis with adjustment for confounding
variables, such as age and BMI, was performed when
necessary. A multiple linear regression was performed to
evaluate the relationship between the calcaneal SOS value
and biochemical determinants. Two separate models were
generated for the total/bioavailable testosterone and total/
bioavailable estradiol to prevent multicollinearity. Estradiol
levels were entered into the regression models as dummy
variables, using the ‘low’ level as the reference group to
which the ‘moderate’ and ‘high’ estradiol level groups were
compared. For continuous data, the standardized coefficient
beta (b) explained the extent of variation in calcaneal SOS
when predictors of interest changed by 1 SD, whereas for
dichotomous data (dummy variables), b explained the
standardized difference of the group in comparison to the
reference group. Significance was set at p,0.05. All
statistical analyses were performed using the Statistical
Package for Social Sciences (SPSS) Version 16.0 (SPSS Inc.,
Chicago, USA).
RESULTS
A total of 570 subjects completed the required screening
procedures, calcaneal SOS measurement, body anthropo-
metric measurements and blood collection. After adjust-
ment for missing values and outliers, data from 549 subjects
(96.32%) were available for analysis. Two hundred forty
subjects (43.7%) were Malay, and 309 subjects (56.3%) were
Chinese. The subjects’ ages ranged from 20 to 83 years, with
a mean of 46.1 years (SD = 15.1 years).
The Malay subjects were significantly younger than the
Chinese subjects were (p,0.05). They also had a significantly
higher weight and shorter stature, thus presenting a higher
BMI than the Chinese subjects (p,0.05). The difference in
calcaneal SOS values between the two ethnic groups was not
significant after adjustment for age and BMI (p.0.05). The
Malay subjects also had significantly higher total serum
calcium and inorganic phosphate levels than the Chinese
subjects (p,0.05), and the significance persisted after adjust-
ment for age. The differences in all sex hormones (total and
bioavailable fractions), intact PTH and SHBG levels between
the two ethnic groups were not significant (p,0.05; Table 1).
Multiple regression analyses revealed that bioavailable
testosterone (b= 0.132, p,0.05) and serum total calcium
(b= 0.091, p,0.05) were significant predictors of the SOS in
men. However, after adjustment for BMI and ethnicity, only
bioavailable testosterone (b= 0.162, p,0.05) was a signifi-
cant predictor of the SOS in the study population, and the
serum total calcium was marginally not significant
(b= 0.081, p = 0.07). After further adjustment for age, the
relationship between the calcaneal SOS value and all
biochemical determinants was not significant (Table 2).
Multiple regression was repeated using total testosterone,
total estradiol and SHBG as predictors. Total testosterone
(b= 0.120, p,0.05) and SHBG (b= -0.149, p,0.05) were
significant predictors of SOS in the study population. The
relationship between total serum calcium and calcaneal SOS
was marginally not significant (b= 0.081, p= 0.068). The
significance for total testosterone (b= 0.156, p,0.05) and
SHBG (b= 0.132, p,0.05) persisted after adjustment for BMI
and ethnicity. However, after further adjustment for age,
none of the biochemical determinants was a significant
predictor of calcaneal SOS (p.0.05).
DISCUSSION
Bone mineral density (BMD) has been associated with
variations in sex hormones. A cross-sectional study con-
ducted by Khosla et al. (1998) revealed that in males, the
BMD at various sites correlated significantly with the
bioavailable testosterone, total estradiol and bioavailable
estradiol, but not with total testosterone. A multiple
regression model in the same study also indicated that
bioavailable estradiol and non-bioavailable estradiol were
significant determinants of BMD (21). This finding was
confirmed by Araujo et al. (2008), who showed that after
various adjustments, total estradiol and free estradiol but
not testosterone levels were significantly correlated with
BMD in males. However, the bioavailable fraction of sex
hormones was not considered in their study (22).
The calcaneal SOS has been shown to reflect bone mineral
density, but its association with sex hormones remains
Table 1 - Characteristics of the study population,
stratified by ethnicity.
Ethnicity Malays Chinese Total
Variable Mean (SD) Mean (SD) Mean (SD)
Age 45.29 (17.38)* 46.80 (13.08) 46.14 (15.11)
Height 165.98 (6.37)* 168.42 (6.31) 167.36 (6.45)
Weight 71.54 (14.36)* 69.06 (12.54) 70.14 (13.40)
BMI 25.94 (4.78)* 24.31 (3.89) 25.02 (4.37)
Calcaneal SOS 1521.30 (27.94) 1515.80 (26.82) 1518.24 (27.43)
Total T 19.18 (6.94)9 18.76 (6.39) 18.94 (6.63)
Bioavailable T 11.09 (3.66) 10.62 (3.46) 10.82 (3.56)
Total calcium 2.29 (0.12)* 2.23 (0.10) 2.26 (0.11)
Inorganic phosphate 1.12 (0.15)* 1.08 (0.15) 1.10 (0.15)
Median (IQR) Median (IQR) Median (IQR)
SHBG 38.63 (28.04) 41.12 (28.31) 39.69 (28.00)
Total E2 87.50 (86.00) 82.00 (112.50) 86.00 (101.00)
Bioavailable E2 60.65 (57.15) 55.13 (77.64) 58.03 (68.91)
Intact PTH 44.58 (21.55) 43.43 (22.34) 43.96 (22.00)
Abbr: SD, standard deviation; IQR, interquartile range; BMI, body mass
index; E2, estradiol; PTH, parathyroid hormone; SOS, calcaneal SOS; T,
testosterone.*Indicates significant differences between Malay and
Chinese subjects (p,0.05). Normally distributed data are presented as the
mean (standard deviation), whereas skewed variables are presented as
the median (interquartile range).
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uncertain. A study conducted by Gennari et al. (2003)
revealed that after adjustment for BMI and age, the
calcaneal SOS correlated significantly with estradiol levels
(total, bioavailable and free fractions), but not with
testosterone levels (total, bioavailable and free fractions)
(23). In comparison, Kuchuk et al. (2007) found significant
differences in the calcaneal SOS value for subjects in the
highest quartile of bioavailable testosterone compared with
lower quartiles; however, similar results were not found for
the bioavailable estradiol level, even though the men in the
lowest quartile for bioavailable estradiol had a lower BMD
and higher bone turnover (24). Vanderschueren et al. (2010)
found that the associations between calcaneal SOS and free
and bioavailable testosterone, sex-hormone binding globu-
lin levels and estradiol levels (total, bioavailable and free
fractions) in 3,141 European males were significant, but no
significant association was found between calcaneal SOS
and total testosterone (25).
In this study, calcaneal SOS measured with the CM-200
was moderately correlated with BMD (r = 0.68) (26). The
calcaneal SOS was significantly associated with bioavailable
testosterone in the unadjusted model; however, it was not
independent of age (when adjusted for age, the relationship
became insignificant). This finding is different from that of
Vanderschueren et al. (2010), who found that the relation-
ship between calcaneal SOS and bioavailable testosterone
was significant when the analysis was adjusted for age (25).
Most studies on the association between calcaneal SOS and
total testosterone indicate a nonsignificant relationship
(23,25); however, in the present study, the relationship
between total testosterone and calcaneal SOS was signifi-
cant. The association of total and free estradiol levels with
calcaneal SOS was generally positive but not significant. In
general, the subjects in the lowest tertile for estradiol levels
had insignificantly lower calcaneal SOS values than subjects
in the higher tertiles. This finding is similar to that of
Kuchuk et al., who reported an insignificant relationship
between SOS and bioavailable estradiol. Kuchuk et al. also
reported a significant relationship between the broadband
attenuation of sound and bioavailable testosterone (24),
which suggests that bioavailable estradiol may exert effects
on bone components that are undetectable using SOS. The
level of sex hormone-binding globulin was significantly and
inversely related to the calcaneal SOS in this study. Sex
hormone-binding globulin reduces the bioavailability of sex
hormones; therefore, it has a negative impact on bone health
(27) that has been shown in previous studies in which lower
SHBG levels in men appeared to offer protection against
osteopenia (28), and men with higher SHBG levels had
greater fracture risk (29).
Variations in calcium absorption play an important role in
bone loss in men. Previous studies indicated a concurrent
decline of calcium absorption and BMD in men (16) that
may result from a decrease in renal function, which in turn
reduces the renal secretion of calcitriol and leads to the
malabsorption of calcium. Consequently, PTH secretion is
induced, and bone resorption occurs (30). Other causes of
calcium imbalance include decreased absorption of vitamin
D (31) and a decreased intestinal response to calcitriol (32).
Most studies have established a significant relationship
between BMD and PTH levels (18,33). Studies examining
the association between calcaneal SOS and PTH or serum
calcium levels are scarce. In the present study, calcaneal SOS
values correlated with total serum levels but not with PTH
level. The transient increase in PTH levels in our subjects
was mild and may not have caused bone mass variations
that were detectable with the QUS technique. It should be
noted that previous findings related to the association
between BMD and PTH levels were established at sites
other than the calcaneus (for example, the hip (34) and the
femoral neck (33)). Hence, it is uncertain how much PTH
variations affect bone mass at the calcaneus. The positive
and significant association between serum total calcium
level and calcaneal SOS suggests that other underlying
causes mediate the relationship between calcium balance
and calcaneal SOS value. A high-protein diet has been
hypothesized to increase calcium excretion (35), but this
possibility was not examined in the present study. Calcium
excretion has also been shown to increase with age (36), and
its effects may not be compensated for, thus creating a
continuous negative calcium balance in the body that
stimulates bone resorption.
Several limitations must be considered in the inter-
pretation of this study’s results. The sampling method
used in the present study was a purposive, nonrando-
mized sampling method; consequently, substantial selec-
Table 2 - Results of a stepwise multiple regression between calcaneal speed of sound values and biochemical
determinants.
Predictors Standardized regression coefficient (b)
Unadjusted Adjusted for ethnicity and BMI Adjusted for ethnicity, BMI and age
1 Bioavailable T 0.132* 0.162* 0.044
Serum total calcium 0.091* 0.081 -0.006
Intact PTH -0.056 -0.069 -0.038
Moderate vs. low bioavailable E2 0.079 0.068 0.062
High vs. low bioavailable E2 0.061 0.058 0.018
2 Total T 0.120* 0.156* 0.046
SHBG -0.149* 0.132* 0.045
Serum total calcium 0.081 0.074 -0.011
Intact PTH -0.066 -0.077 -0.042
Moderate vs. total E2 0.082 0.078 0.067
High vs. low total E2 0.063 0.066 0.031
Abbr: E2, estradiol; T, testosterone; SHBG, sex hormone-binding globulin.
*Indicates p.0.05. For continuous data, the standardized coefficient beta (b) explained the extent of the variation in calcaneal SOS when the predictor of
interest changed by 1 SD, whereas for dichotomous data (dummy variables), b explained the standardized difference of the group compared with the
reference group.
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tion bias may have been introduced during recruitment,
and the results should be generalized with caution. The
QUS device used, the CM-200, generates only one QUS
index: calcaneal SOS. Other indices, such as broadband
attenuation of sound and stiffness index, were not
evaluated. The true calcium absorption and excretion
were not measured in the present study; consequently, the
calcium balance observed was based on the serum total
calcium level alone and may not be adequate. Calcitriol
levels and dietary calcium consumption among the
subjects were not investigated in the present study;
consequently, the variations in calcium level could not
be fully explained. We experienced substantial difficulty
in comparing the regression model generated in the
present study with the literature because previous studies
did not report their linear regression procedures in detail.
Multicollinearity issues created by entering the total and
bioavailable or free sex hormones into the same regression
model were also apparent in previous studies. In the
present study, the total and bioavailable sex hormones
were entered into two separate regression models so that
the results presented are valid and unaffected by multi-
collinearity.
In conclusion, SHBG and total and bioavailable testoster-
one are significantly associated with calcaneal SOS values in
men, and the relationships are age-dependent. The relation-
ship between total serum calcium and calcaneal SOS is
ethnicity-dependent. Pharmacologic interventions for the
age-dependent deterioration of bone health in men should
aim to maintain optimal bioavailable testosterone and
calcium levels.
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